Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HL-1186 tablets for orthopedic postoperative analgesia (Phase II/III)
ChiCTR2600122899Phase 3Not yet recruiting
- Sponsor
- The Third Xiangya Hospital of Central South University, Sichuan Provincial People's Hospital
- Start
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of HL-1186 in postoperative pain (7 arms), sponsored by The Third Xiangya Hospital of Central South University, Sichuan Provincial People's Hospital. Primary endpoint: SPID0-48 at rest. Planned start Apr 2026; status: not yet recruiting.
02
Drugs
HL-1186
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2600122899.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600122899.